This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collin, M.
Right arrow Articles by Olsén, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collin, M.
Right arrow Articles by Olsén, A.

 Previous Article  |  Next Article 

Infection and Immunity, December 2002, p. 6646-6651, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.6646-6651.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

EndoS and SpeB from Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis

Mattias Collin,1,{dagger} Mikael D. Svensson,2 Anders G. Sjöholm,2 Jens C. Jensenius,3 Ulf Sjöbring,2 and Arne Olsén1*

Department of Cell and Molecular Biology, Lund University, S-221 84 Lund,1 Institute of Laboratory Medicine, University Hospital of Lund, S-221 85 Lund, Sweden,2 Department of Medical Microbiology and Immunology, University of Aarhus, DK-8000 Aarhus, Denmark3

Received 20 May 2002/ Returned for modification 14 August 2002/ Accepted 26 August 2002

The human pathogen Streptococcus pyogenes primarily infects the upper respiratory tract and skin, but occasionally it disseminates and causes severe invasive disease with high mortality. This study revealed that the activity of extracellular EndoS, which hydrolyzes the functionally important N-linked oligosaccharides on opsonizing immunoglobulin G (IgG), contributes to increased survival of S. pyogenes in human blood ex vivo. The inability to kill the bacteria is due to reduced binding of IgG to Fc receptors and impaired classical pathway-mediated activation of complement. In addition, the activity of extracellular SpeB, which cleaves IgG into Fc and Fab fragments, also increases bacterial survival. This suggests that S. pyogenes expresses two enzymes, EndoS and SpeB, which modulate IgG by different mechanisms in order to evade the adaptive immune system.

* Corresponding author. Present address: Department of Clinical Immunology, Göteborg University, Guldhedsgatan 10A, S-413 46 Göteborg, Sweden. Phone: 46 31 342-4895. Fax: 46 31 342-4621. E-mail: arne.olsen{at}immuno.gu.se.

Editor: J. T. Barbieri

{dagger} Present address: Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY 10021.

Infection and Immunity, December 2002, p. 6646-6651, Vol. 70, No. 12
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.12.6646-6651.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Andreasen, C., Carbonetti, N. H. (2009). Role of Neutrophils in Response to Bordetella pertussis Infection in Mice. Infect. Immun. 77: 1182-1188 [Abstract] [Full Text]  
  • Collin, M., Shannon, O., Bjorck, L. (2008). From the Cover: IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc. Natl. Acad. Sci. USA 105: 4265-4270 [Abstract] [Full Text]  
  • Kuo, C.-F., Lin, Y.-S., Chuang, W.-J., Wu, J.-J., Tsao, N. (2008). Degradation of Complement 3 by Streptococcal Pyrogenic Exotoxin B Inhibits Complement Activation and Neutrophil Opsonophagocytosis. Infect. Immun. 76: 1163-1169 [Abstract] [Full Text]  
  • Yuste, J., Ali, S., Sriskandan, S., Hyams, C., Botto, M., Brown, J. S. (2006). Roles of the Alternative Complement Pathway and C1q during Innate Immunity to Streptococcus pyogenes. J. Immunol. 176: 6112-6120 [Abstract] [Full Text]  
  • Rebe, S., Solomon, B. (2005). Deglycosylation of anti-{beta} amyloid antibodies inhibits microglia activation in BV-2 cellular model. AM J ALZHEIMERS DIS OTHER DEMEN 20: 303-313 [Abstract]  
  • Wei, L., Pandiripally, V., Gregory, E., Clymer, M., Cue, D. (2005). Impact of the SpeB Protease on Binding of the Complement Regulatory Proteins Factor H and Factor H-Like Protein 1 by Streptococcus pyogenes. Infect. Immun. 73: 2040-2050 [Abstract] [Full Text]  
  • Voyich, J. M., Braughton, K. R., Sturdevant, D. E., Vuong, C., Kobayashi, S. D., Porcella, S. F., Otto, M., Musser, J. M., DeLeo, F. R. (2004). Engagement of the Pathogen Survival Response Used by Group A Streptococcus to Avert Destruction by Innate Host Defense. J. Immunol. 173: 1194-1201 [Abstract] [Full Text]  
  • Collin, M., Fischetti, V. A. (2004). A Novel Secreted Endoglycosidase from Enterococcus faecalis with Activity on Human Immunoglobulin G and Ribonuclease B. J. Biol. Chem. 279: 22558-22570 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»